How a French Physician Transformed Our Understanding of Down Syndrome and Human Genetics

Health · Published 3 October 2026 Swipe more like this →

In short: In the 1950s, Down syndrome was often wrongly attributed to parental alcoholism or racial defects. Jérôme Lejeune shattered these stigmas by identifying the condition’s true biological origin. His discovery of an extra chromosome not only redefined medical science but also launched the entire field of modern cytogenetics.

Born in 1926, Jérôme Lejeune was a French physician whose career began with a focus on the effects of atomic radiation on human heredity. Working at the Armand-Trousseau Hospital in Paris under Raymond Turpin, Lejeune sought to understand the genetic roots of developmental disorders. At the time, the scientific community lacked a clear explanation for Down syndrome, leading to widespread social prejudice against affected children and their families. Lejeune, driven by compassion, aimed to replace these misconceptions with rigorous scientific evidence.

The breakthrough occurred in 1958, following the 1956 discovery by researchers in Sweden that humans possess forty-six chromosomes. Working with Marthe Gautier, who had established a cell culture laboratory at the hospital, Lejeune examined tissue samples from patients. On 22 May 1958, he observed a forty-seventh chromosome in a child with Down syndrome, identifying it as an extra copy of the twenty-first chromosome. This finding, published in the journal of the Académie des Sciences on 26 January 1959, officially introduced the term Trisomy 21 to the medical lexicon.

The discovery was not without later controversy regarding credit. While Lejeune was the first author on the seminal 1959 paper, Gautier later asserted that she had prepared the critical slides and first noticed the discrepancy in chromosome count. Despite these disputes, the impact of the work was undeniable. It provided a concrete biological explanation for developmental anomalies, effectively ending the era of blaming parents for their children's conditions. Lejeune went on to identify other chromosomal abnormalities, such as cri du chat syndrome in 1963 and 18q-Syndrome in 1966, cementing his role as a pioneer in cytogenetics.

Beyond his laboratory work, Lejeune became a prominent advocate for the pro-life movement, frequently discussing the ethics of prenatal testing with Pope John Paul II. He maintained that a physician’s role was to combat the condition while showing unconditional love for the patient. His legacy remains complex, balancing his monumental contribution to medical science with his vocal stance on the ethical implications of genetic screening and abortion.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• Extra chromosome 21 reshapes development, not destiny alone
• A single chromosomal error can rewrite a human life's blueprint
• For 33 years scientists confidently miscounted human chromosomes as 48
• From pea plants to the double helix: how we decoded the blueprint of life
• The biological blueprint that makes every human being unique
• The Congolese scientist who survived his first encounter with the deadly Ebola virus
• The Australian veterinary scientist who became the architect of a national scientific boom
• How a Parisian doctor turned the study of the brain into a modern science
• How a Welsh bone-setter revolutionized orthopedics by demanding absolute stillness for broken bones
• John Hunter transformed surgery from a mechanical craft into a rigorous experimental science.
• The Father of Space Medicine was a key figure in Nazi-era human experimentation.
• The Japanese bacteriologist who pioneered serum therapy and identified the bubonic plague agent

More in Medicine · More in Health · Latest · A–Z · All topics